Balance Sheet Components (Tables)
|
3 Months Ended |
Mar. 31, 2026 |
|---|
| Balance Sheet Related Disclosures [Abstract] |
|
| Schedule of Prepaid Expenses and Other Current Assets |
The following table presents the components of prepaid expenses and other current assets as of March 31, 2026 and December 31, 2025 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
|
|
2026 |
|
|
2025 |
|
Prepaid clinical expenses |
|
$ |
3,326 |
|
|
$ |
4,020 |
|
Interest and investment receivables |
|
|
989 |
|
|
|
298 |
|
Prepaid expenses |
|
|
605 |
|
|
|
1,069 |
|
Prepaid insurance |
|
|
295 |
|
|
|
530 |
|
Other current assets |
|
|
25 |
|
|
|
20 |
|
Total prepaid expenses and other current assets |
|
$ |
5,240 |
|
|
$ |
5,937 |
|
|
| Schedule of Components of Property and Equipment |
The following table presents the components of property and equipment, net as of March 31, 2026 and December 31, 2025 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
|
|
2026 |
|
|
2025 |
|
Laboratory equipment |
|
$ |
1,844 |
|
|
$ |
1,844 |
|
Leasehold improvements |
|
|
709 |
|
|
|
709 |
|
Computer hardware and software |
|
|
416 |
|
|
|
461 |
|
Furniture and fixtures |
|
|
165 |
|
|
|
165 |
|
Property and equipment, gross |
|
|
3,134 |
|
|
|
3,179 |
|
Less: accumulated depreciation |
|
|
(2,084 |
) |
|
|
(1,979 |
) |
Property and equipment, net |
|
$ |
1,050 |
|
|
$ |
1,200 |
|
|
| Schedule of Components of Other Assets, Net |
The following table presents the components of other assets as of March 31, 2026 and December 31, 2025 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
|
|
2026 |
|
|
2025 |
|
Finance lease right-of-use assets |
|
$ |
1,274 |
|
|
$ |
1,513 |
|
Operating lease right-of-use assets |
|
|
1,010 |
|
|
|
1,159 |
|
Long-term prepaid clinical expenses |
|
|
386 |
|
|
|
693 |
|
Other assets |
|
|
148 |
|
|
|
149 |
|
Long-term prepaid contract manufacturing costs |
|
|
113 |
|
|
|
111 |
|
Total other assets |
|
$ |
2,931 |
|
|
$ |
3,625 |
|
|
| Components of Accrued Expenses and Other Current Liabilities |
The following table presents the components of accrued expenses and other current liabilities as of March 31, 2026 and December 31, 2025 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
|
|
2026 |
|
|
2025 |
|
Accrued clinical and nonclinical study costs |
|
$ |
5,364 |
|
|
$ |
6,196 |
|
Other current liabilities |
|
|
2,225 |
|
|
|
2,323 |
|
Accrued compensation and related expenses |
|
|
1,804 |
|
|
|
4,356 |
|
Accrued contract manufacturing |
|
|
1,504 |
|
|
|
1,341 |
|
Accrued property and equipment |
|
|
210 |
|
|
|
206 |
|
Total accrued expenses and other current liabilities |
|
$ |
11,107 |
|
|
$ |
14,422 |
|
|